Yildiz Ali, Demirbag Recep, Yilmaz Remzi, Gur Mustafa, Altiparmak Ibrahim H, Akyol Selahattin, Aksoy Nurten, Ocak Ali R, Erel Ozcan
Department of Cardiology, Harran University, School of Medicine, Sanliurfa, Turkey.
Coron Artery Dis. 2008 Aug;19(5):319-25. doi: 10.1097/MCA.0b013e32830042ba.
Prolidase is a cytosolic exopeptidase that cleaves iminodipeptides with carboxy-terminal proline or hydroxyproline and plays major role in collagen turnover. Collagen is the essential content in atherosclerotic plaque playing a key role in the stability/instability of and progression of coronary artery disease (CAD). Consequently, in this study we sought to determine serum prolidase activity and markers of oxidative stress such as lipid hydroperoxide and total free sulfhydryl in CAD.
We have evaluated 199 patients with CAD and 122 control cases with clinical, electrocardiographic, and laboratory investigation. We have measured serum prolidase activity and serum total free sulfhydryl levels spectrophotometrically. Serum lipid hydroperoxide levels were determined with ferrous ion oxidation-xylenol orange method. We assessed the association of serum prolidase activity with the presence and severity of CAD and clinical characteristics, and laboratory parameters.
Serum prolidase activity (52.5+/-5.6 vs. 46.7+/-5.1 U/l, respectively, P<0.001) and serum lipid hydroperoxide levels were significantly increased in patients with CAD compared with control cases whereas, serum total free sulfhydryl levels were significantly decreased in patients with CAD compared with control cases. Serum prolidase activity and total free sulfhydryl levels were independent predictors of the presence of CAD [(chi=75.532, ss=0.212, P=0.003) and (chi=25.969, ss=-30.486, P=0.019), respectively] and Gensini score [(beta=0.276, P<0.001) and (beta=-0.274, P<0.001), respectively]. Independent predictors of serum prolidase activity were serum high-density lipoprotein cholesterol (beta=-0.138, P=0.023) and urea levels (beta=0.146, P=0.036), and Gensini score (beta=0.317, P<0.001).
Findings of this study have shown that serum prolidase activity is significantly associated with the presence and severity of CAD, and elevated serum prolidase activity might be an independent predictor of coronary atherosclerosis.
脯氨酰寡肽酶是一种胞质外肽酶,可裂解羧基末端为脯氨酸或羟脯氨酸的亚氨基二肽,在胶原蛋白代谢中起主要作用。胶原蛋白是动脉粥样硬化斑块的重要成分,在冠状动脉疾病(CAD)的稳定性/不稳定性及进展中起关键作用。因此,在本研究中,我们试图测定CAD患者血清脯氨酰寡肽酶活性以及氧化应激标志物,如脂质氢过氧化物和总游离巯基。
我们对199例CAD患者和122例对照者进行了临床、心电图及实验室检查评估。我们采用分光光度法测定血清脯氨酰寡肽酶活性和血清总游离巯基水平。采用亚铁离子氧化 - 二甲苯酚橙法测定血清脂质氢过氧化物水平。我们评估了血清脯氨酰寡肽酶活性与CAD的存在、严重程度以及临床特征和实验室参数之间的关联。
与对照组相比,CAD患者的血清脯氨酰寡肽酶活性(分别为52.5±5.6 vs. 46.7±5.1 U/l,P<0.001)和血清脂质氢过氧化物水平显著升高,而CAD患者的血清总游离巯基水平与对照组相比显著降低。血清脯氨酰寡肽酶活性和总游离巯基水平分别是CAD存在的独立预测指标[(χ=75.532,ss=0.212,P=0.003)和(χ=25.969,ss=-30.486,P=0.019)]以及Gensini评分的独立预测指标[(β=0.276,P<0.001)和(β=-0.274,P<0.001)]。血清脯氨酰寡肽酶活性的独立预测指标是血清高密度脂蛋白胆固醇(β=-0.138,P=0.023)、尿素水平(β=0.146,P=0.036)以及Gensini评分(β=0.317,P<0.001)。
本研究结果表明,血清脯氨酰寡肽酶活性与CAD的存在和严重程度显著相关,血清脯氨酰寡肽酶活性升高可能是冠状动脉粥样硬化的独立预测指标。